A US-based generic medicines-producing pharmaceutical company approached Freyr for Regulatory support for the compilation, evaluation, and submission of an Annual Report (AR) to the United States Food and Drug Administration (US FDA). This included proper coordination of the Publishing Team, our US local agents and finally submitting them to the Health Authority i.e. US FDA via electronic submission gateway (ESG).
Download the proven case to learn how Freyr’s RA team addressed and solved the client’s AR challenges and provided the required guidance in the entire process.
Fill the form below to download the Case Study
